Andrew E. Place
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Toxicology top 5%
Papers in
-
- Acute Lymphoblastic Leukemia research 33
- Hematology 18
- Acute Myeloid Leukemia Research 12
- Chronic Myeloid Leukemia Treatments 4
- Hematopoietic Stem Cell Transplantation 3
- Co-authors
- Kornélia Polyák (2 shared papers)Sung Jin Huh (1 shared paper)Tadashi Honda (4 shared papers)Gordon W. Gribble (4 shared papers)Michael B. Sporn (4 shared papers)Nanjoo Suh (4 shared papers)Yukiko Honda (3 shared papers)Renee Risingsong (3 shared papers)
- Journals
- Blood (19 papers)Journal of Clinical Oncology (7 papers)Blood Advances (4 papers)Pediatric Blood & Cancer (4 papers)Cancer Research (3 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Andrew E. Place
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 96
- Hematology 203
- Toxicology 63
- Oncology 432
- Cancer Research 208
- Molecular Biology 843
Countries citing papers authored by Andrew E. Place
This map shows the geographic impact of Andrew E. Place's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Place with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Place more than expected).
Fields of papers citing papers by Andrew E. Place
This network shows the impact of papers produced by Andrew E. Place. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Place. The network helps show where Andrew E. Place may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew E. Place, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 330 | |
| 2 | 2005 | 247 | |
| 3 | 2002 | 133 | |
| 4 | The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo. | 2003 | 126 |
| 5 | 1999 | 123 | |
| 6 | 2016 | 102 | |
| 7 | 2016 | 87 | |
| 8 | Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. | 2003 | 79 |
| 9 | 2018 | 72 | |
| 10 | 2018 | 48 | |
| 11 | 2018 | 41 | |
| 12 | 2013 | 28 | |
| 13 | 2022 | 25 | |
| 14 | 1999 | 23 | |
| 15 | 2023 | 20 | |
| 16 | 2019 | 18 | |
| 17 | 2019 | 12 | |
| 18 | 2023 | 12 | |
| 19 | 2021 | 11 | |
| 20 | 2021 | 11 |
About Andrew E. Place
Andrew E. Place is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 57 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (33 papers), Childhood Cancer Survivors' Quality of Life (13 papers), Acute Myeloid Leukemia Research (12 papers), Chronic Lymphocytic Leukemia Research (7 papers), Neuroblastoma Research and Treatments (5 papers), Chronic Myeloid Leukemia Treatments (4 papers), CAR-T cell therapy research (4 papers) and Hematopoietic Stem Cell Transplantation (3 papers). The work is most often cited by research in Hematology (203 citations), Toxicology (63 citations), Oncology (432 citations), Cancer Research (208 citations) and Molecular Biology (843 citations). Andrew E. Place has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kornélia Polyák, Sung Jin Huh, Tadashi Honda, Gordon W. Gribble, Michael B. Sporn, Nanjoo Suh, Yukiko Honda, Renee Risingsong, Charlotte R. Williams and Karen T. Liby. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Pediatric Blood & Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.